Attenua competitorsClear all

Attenua's top competitors include India Globalization Capital, LTS Lohmann Therapie-Systeme, KSQ Therapeutics and Tarveda Therapeutics.
Attenua
Attenua
Attenua is a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough.
India Globalization Capital
India Globalization Capital
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
KSQ Therapeutics
KSQ Therapeutics
KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.
Tarveda Therapeutics
Tarveda Therapeutics
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.
Founding Date
Founding Date
2015
Founding Date
2005
Founding Date
1984
Founding Date
2015
Founding Date
2011
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
HQ
Locations
Bethesda, US HQ
Locations
Andernach, DE HQ
Shanghai, CN
West Caldwell, US
Locations
Cambridge, US HQ
Locations
Watertown, US HQ
Employees
Employees
8
Employees
2025% increase
Employees
N/A
Employees
852% decrease
Employees
343% decrease
Twitter followers
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
170
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.7
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
956971
Alexa Website Rank
275452
Alexa Website Rank
628090
Alexa Website Rank
2270128

Funding

Latest funding round
Latest funding round
$ 35m (over 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 80m (about 1 year ago)
Latest funding round
$ 30m (almost 3 years ago)
Total funding raised
Total funding raised
$ 35m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 156m
Total funding raised
$ 158.6m
For sources of this data, please see the company profile

View company profiles

India Globalization Capital
HQ
Bethesda, US
Employees
20↑ 25% increase

India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.

View company
LTS Lohmann Therapie-Systeme
HQ
Andernach, DE

LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.

View company
KSQ Therapeutics
HQ
Cambridge, US
Employees
85↓ 2% decrease

KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.

View company
Tarveda Therapeutics
HQ
Watertown, US
Employees
34↓ 3% decrease

Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.

View company